AI in biotech sparks biosecurity debate: can safeguards keep pace?
AI-based biology tools can design proteins, toxins, and even viruses, prompting debate over safeguards: some researchers say current risk is limited and production requires expertise, while others warn AI could empower bad actors. The discussion spans whether to restrict biological AI or to improve detection and screening of DNA orders; experiments show screening can be bypassed but improvements reduce risk. Policy efforts such as DNA-synthesis screening, guard rails, and international guidelines are evolving as scientists push for responsible AI practices, acknowledging the threat is serious but not inevitable.
